Skip to main content
Skip to main navigation
Search for :
Product Development Strategy
Early Clinical Development
Phase I/IIa Clinical Trials
Phase II/III Clinical Trials
Interventional Phase IIIb/Phase IV Clinical Trials
Observational Research & Registries
Product Launch & Management
Market Access Solutions
Strategic Sales Outsourcing
Biopharmaceutical Sales & Marketing
Payers & Providers
Medical Device & Diagnostics
Public Health & Government
Small to Mid-Sized Biopharma
Specialty Clinical Associations and Patient Organizations
Central Nervous System
Diabetes & Endocrinology
Early Phase Oncology
Public Health Interest
Other Therapeutic Areas
Ethics & Compliance
The New Health Report is a report based on a national survey of biopharmaceutical executives, managed care executives, physicians and patients living with chronic disease conducted by Richard Day Research of Evanston, Ill., on behalf of Quintiles Transnational Corp. Richard Day Research was responsible for all survey design, data analysis and data reporting.
Data for this survey were collected between January 5 and February 27, 2011. Included in the sample were 200 biopharmaceutical executives at the director level or above, 153 managed care executives at the director level or above, 400 primary care physicians, 103 board-certified specialists, and 1,000 U.S. adults ages 18+ diagnosed with a chronic health condition who are receiving treatment.
Professionals were recruited via postal mail, telephone, fax and e-mail and completed the survey in a self-administered online questionnaire. Patient interviews were conducted via landline and cellular telephone.
With pure probability samples of these sizes, one could say with 95 percent probability that the results have a sampling error of +/- 7 percentage points for biopharmaceutical executives, +/- 8 percentage points for managed care executives, +/- 4 percentage points for physicians and +/- 3 percentage points for patients.
Download | 2011 New Health Report
Jay Norman discusses the survey's findings
Key Finding | Are you pessimistic or optimistic that the quality of the following will be significantly improved 10 years from now?
Key Finding | How effective do you feel patients are in:
Key Finding | In your own words, how would you define "value" in healthcare?
Dr. Oren Cohen on The New Health Report
Key Finding | Overall, do you approve of the job each of the following are doing to improve health outcomes in the United States?
Forward-Looking StatementsThis site and its related links, including videos, and other content may contain forward-looking statements that reflect, among other things, Quintiles' current thinking, expectations and ideas, all of which are subject to known and unknown risks, uncertainties and other factors that may cause market trends, industry results or Quintiles' actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. Any statements contained on this site or in its related links that are not statements of historical fact are forward-looking statements and should be evaluated as such. Without limiting the foregoing, the words "anticipates," "believes," "estimates," "expects," "intends," "may," "plans," "projects," "should," "targets," "will" and the negative thereof and similar words and expressions are intended to identify forward-looking statements. These statements are subject to risks, uncertainties and assumptions and are imprecise by their very nature. For more information regarding these risks as they may affect Quintiles, please see the risk factors identified in Quintiles' filings with the Securities and Exchange Commission, which are available in the Investors Relations section of Quintiles' website at www.quintiles.com. Unless legally required, Quintiles assumes no obligation to update any such forward-looking information to reflect actual results or changes in the factors affecting such forward-looking information.